World

EU spent €381.4 billion on R&D in 2023

Dec 12, 2024

Brussels [Belgium], December 12: In 2023, the EU spent €381.4 billion on research & development (R&D), which is 6.7% more than in the previous year (€357.4 billion) and 57.9% more than in 2013 (€241.5 billion).
R&D intensity, defined as R&D expenditure as a percentage of GDP, remained stable compared with 2022 (2.2%). Between 2013 and 2023, R&D intensity in the EU increased by 0.1 percentage points (pp).
Between 2013 and 2023, R&D intensity increased in 19 EU countries, with the largest increases recorded in Belgium (1.0 pp), Poland (0.7 pp) and Greece (0.7 pp).
In 2023, 5 EU countries registered an R&D intensity above 3%. The highest R&D intensity was recorded in Sweden (3.6%), Belgium and Austria (3.3% each). Germany and Finland followed with 3.1% each.
By contrast, 5 EU countries reported R&D intensity below 1%: Romania (0.5%), Malta (0.6%), Cyprus (0.7%), Bulgaria and Latvia (both 0.8%).
The business enterprise sector continued to account for the largest share of R&D expenditure. In 2023 it represented 66% of EU R&D spending, totalling €253.1 billion. It was followed by the higher education sector (€81.7 billion; 21%), the government sector (€41.0 billion; 11%), and the private non-profit sector (€5.5 billion; 1%).
Source: Emirates News Agency

More news

Star Health settles over ₹780 crore in cancer claims in H1 FY27; highlights women's treatment and financial protection needs

Chennai (Tamil Nadu) [India], November 6: Star Health and Allied Insurance Company Limited (NSE: STARHEALTH) (BSE: 543412), one of India's leading Health Insurance companies, settled over 85,900 cancer-related claims*2 worth over ₹780 crores during H1 FY27. Nearly 30% of this has been for people aged between 51 and 60 years. Women accounted for approximately 60% of these cancer claims, with settlements for women increasing 17% Year-on-Year. These figures illustrate the scale of financial support accessed by insured women and their families during cancer treatment.

Nov 06, 2026